Home
Search:
1146 feeds
357 categories
13506 articles (<24 hours)
87 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


Valid HTML 4.01 Transitional

RSS FeedsMerck KGaA, Darmstadt, Germany Receives Approval (Updated Registration) for Cladribine Tablets in Australia
(WorldNews Germany)

 
 

7 december 2017 11:13:20

 
Merck KGaA, Darmstadt, Germany Receives Approval (Updated Registration) for Cladribine Tablets in Australia
(WorldNews Germany)
 




About Cladribine Tablets Cladribine Tablets is an investigational short-course oral therapy that is thought to selectively target lymphocytes thought to be integral to the pathological process of relapsing MS (RMS). Cladribine Tablets is currently under clinical investigation and not yet approved for any use in the United States. In August 2017, the European Commission (EC) granted marketing authorization for Cladribine Tablets, marketed as MAVENCLAD, for the treatment of adult patients with highly active relapsing forms of multiple sclerosis (RMS) as defined by clinical or imaging features in the 28 countries of the European Union (EU) in addition to Norway, Liechtenstein and Iceland. In...
 
3 viewsCategory: General > Europe > Germany
 
Success model: Speedmaster XL 106 from Heidelberg unmatched in productivity and efficiency
(WorldNews Germany)
Mitsui Chemicals Agro, Inc. (MCAG) and BASF sign commercialization agreement for new insecticide with IRAC novel mode of action
(WorldNews Germany)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2017 Indigonet Services B.V.. Contact: Tim Hulsen
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn
Indigonet Services BV is not responsible for any incorrect or outdated information on this site.
If, however, you would like to see an article removed, you can send us an e-mail quoting the article number.